Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A ten-year comparison of Aristocrats ETFs highlights performance patterns, dividend consistency, and growth trajectory to aid selection.
27,377 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A Trump-era regulatory push aims to bring major crypto firms into the federal banking system, signaling a potential o...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
Young graduates facing scarce first jobs as data show the entry-level market worst it’s unfolding despite a steadier ...
A Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
Umbra has publicly released its private wallet for Solana, enabling shielded transfers, encrypted swaps, and new comp...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
Wheaton's Q1 2026 earnings transcript offers clues about margins, cash flow, and future growth in the gold streaming ...
A new AHLA survey shows bookings lag the World Cup 2026 fever in U.S. host markets. The industry cites visa delays, g...
As negotiators in Beijing steer talks between the U.S. and China, investors are eyeing three names likely to move: NV...
Stocks surged on a report of a potential Apple manufacturing pact with Intel, propelling INTC higher as markets weigh...